Evidence map›Paper›PMID 41262417›Full record

ArticleThe Lancet regional health. Europe2025

Care and outcomes of first-time myocardial infarction among vulnerable populations in Denmark, 2003-22: a nationwide registry-based cohort study.

Clara Friis, Sofie-Louise Feentved Ødum, Caroline Hartwell Garred, Deewa Zahir Anjum, Marte Austreim, Camilla Fuchs Andersen, Nina Nouhravesh, Emil Fosbøl, Lars Køber, Daniel Mølager Christensen and 3 more

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Clara FriisDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Sofie-Louise Feentved ØdumDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Caroline Hartwell GarredDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Deewa Zahir AnjumDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Marte AustreimDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Camilla Fuchs AndersenDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Nina NouhraveshDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Emil FosbølDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Lars KøberDepartment of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Daniel Mølager ChristensenDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Morten MalmborgDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Morten SchouDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Mariam ElmegaardDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mortality following a first-time myocardial infarction (MI) has declined, yet disparities in treatment and outcomes among potentially vulnerable groups remain unclear. We aimed to examine trends in treatment and mortality among first-time MI patients from 2003 to 2022 across eight potentially vulnerable subgroups in Denmark. Methods: Using Danish registries, patients with a first-time MI between 2003 and 2022 were identified and divided into five-year calendar groups and eight subgroups ('age ≥80', 'low income', 'female', 'frail', 'non-Western immigrant', 'history of mental illness', 'living alone', and 'living in a rural area'). Temporal trends in treatment initiation and mortality were assessed using Kaplan Meier estimates and multivariable Cox regression. Findings: Among 118,674 patients included, guideline-recommended therapy initiation increased over time, though gaps persisted (e.g. statin initiation in 2018-2022: 77.0% (2241/2911) among frail patients vs. 90.2% (19,986/22,157) among their counterparts). Crude and adjusted mortality rates declined for all subgroups over time, yet gaps persisted. Mortality remained highest among frail patients (5-year mortality risk of 48.7% [95% CI 46.5-50.9] in 2018-2022) and those aged ≥80 years (56.5% [95% CI 54.5-58.5]), no mortality difference was observed between patients living in rural areas and their counterparts (21.6% [95% CI 20.6-22.6] vs. 21.3% [95% CI 19.8-20.6] in 2018-2022), and non-Western immigrants exhibited lower mortality than their counterparts (8.8% [95% CI 7.0-10.6] vs. 21.3% [95% CI 20.7-22.0] in 2018-2022). Interpretation: Despite improvements from 2003 to 2022, persistent disparities underscore ongoing inequities and the need for targeted efforts to promote equity. Funding: None.

Indexed as

InequityMortalityMyocardial infarctionTemporal trendsTreatment

Identifiers

PMID41262417
PMCPMC12624803

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.